Email Updates

Search form

You are here

Px Pulse

Px Pulse is a project of AVAC and our partners in the Coalition to Accelerate and Support Prevention Research. Each month this podcast will use interviews, discussion and first-person reflections to explore vital topics confronting the field of HIV prevention research.

Px Pulse features in-depth conversations with voices from the field or listen to highlighted selections from those interviews.

Give these a listen. We're very interested to hear your thoughts!

Px Pulse Banner Image

2018 and HIV Prevention: AVAC's Take (8:04)
January 10, 2018
In this episode hear about recently published findings from a study out of Rakai, Uganda confirm that scaling up of a combination of existing interventions, such as voluntary medical male circumcision and antiretroviral therapy provides protection from HIV at the population-level. How do we apply these findings at the global level? How should advocates prepare for results—anticipated in 2019—of the ECHO trial that’s looking at the effect of hormonal contraceptives on HIV risk? And what needs to happen in 2018 to reach long-term global targets for ending the epidemic?

What’s the State of the Field? AVAC Report 2017 (14:34)
December 19, 2017
In this month's episode of Px Pulse, AVAC's Diretor of Strategy & Content Emily Bass shares highlights from our annual report, Mixed Messages and How to Untangle Them, and calls for action on the unfinished work of scaling up prevention.

Standard of Care in the Era of PrEP (18:07)
November 22, 2017
Every research trial of a new HIV prevention option offers a package of services to protect participants from HIV. This standard of care is essential to the design of an ethical trial.

Trial Trial Again: Getting research right for adolescents (11:28)
October 12, 2017
Both research and advocacy for HIV prevention are intensifying their focus on young people. Bringing interventions that work for this population holds unique challenges. AVAC’s Manju Chatani-Gada explores how and why prevention research must reach the next generation.

Testing Long-Acting PrEP, Easier Said Than Done (11:56)
October 12, 2017
Leading researcher Dr. Deborah Donnell tells us why the HIV Prevention Trials Network (HPTN) changed the design of one of two trials testing long-acting cabotegravir, as an injectable PrEP.

PrEP and Trial Design — A no brainer for some (6:15)
September 22, 2017
Slim Abdool Karim, co-principal investigator of the landmark CAPRISA 004 study, talks about why designing trials with oral PrEP is a must—scientifically and ethically.

Golden Age or Fools Gold? (3:26)
September 13, 2017
Carl Dieffenbach, Director of NIH’s Division of AIDS, tells AVAC where he sees the most promise in the field of HIV prevention and what it will take to “put out the fire.”